Sun Pharmaceutical Industries Ltd and Sun Pharma Advanced Research Company (SPARC) on Thursday said they have entered into a worldwide licensing pact for development and commercialisation of a novel molecule which can be used for the potential treatment of atopic dermatitis, psoriasis and other auto-immune disorders
US Food and Drug Administration flags Sun Pharma's Halol plant, warns product approvals may be put on hold
Sun Pharmaceutical Industries seems to have suffered a setback as the US Food and Drug Administration (FDA) has placed its Halol plant under ‘official action indicated’.
In January this year, Sun Pharma had announced a slew of measures, including replacement of its domestic formulations distributor Aditya Medisales and change of auditors for its arms.
Sun Pharma's MD Dilip Shanghvi says shareholders not disadvantaged in transactions with Aditya Medisales
Drug major Sun Pharmaceutical Industries has said its shareholders were not disadvantaged in transactions with Aditya Medisales and the company has responded to queries from market regulator Sebi
Sun Pharma shares pledged to raise fund for Suraksha; realty firm uses same method thrice in past two years for money
Shanghvi Finance, which is a major shareholder in Sun Pharma, pledged a portion of its stake in India’s largest drugmaker to facilitate Suraksha Realty for raising Rs 100 crore through commercial paper.
Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker
In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges
Shares of Sun Pharmaceutical fell over 3 percent on Thursday, a day after markets regulator SEBI said it is examining the whistleblower complaint against the company.
Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi
Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance
Sun Pharma shares slump 10% as SEBI plans to reopen insider trading case to probe alleged lapses by some of its promoters
Shares of Sun Pharmaceutical tumbled over 10 percent on Monday as markets regulator SEBI may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters
Sensex surges over 200 points on US-China trade truce; Nifty up; metal, realty, FMCG stocks biggest gainers
The Sensex was trading 181.52 points, or 0.50 percent, higher at 36,375.82 at 0945 hrs.
Forbes billionaires 2018 ranking: With $40 bn, Mukesh Ambani richest Indian; Jeff Bezos tops global rich list
Mukesh Ambani's net worth has soared to $40.1 billion, making him the richest Indian for the 11th year in a row, while Amazon founder Jeff Bezos toppled Bill Gates as the world's wealthiest person, says Forbes
According to the Forbes list, the total wealth of India's top 100 billionaires, which stands at a whopping $479 billion, is more than the country's foreign exchange reserves estimated at $402.5 billion in September 2017
The company's total income from operations rose however to Rs 7,912.66 crore for the third quarter of the current fiscal, from Rs 7,122.31 crore in the year-ago period
Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion
When the RBI commenced the licencing process for payments banks, the idea was to offer one more layer of payments services to the yet-to-be banked in the country.
They are the second applicant to withdraw from the licence after Cholamandalam group pulled out of payments banks race a couple of months back
Mukesh Ambani, Azim Premji and Dilip Shanghvi - have made it to a global list of 50 wealthiest people that is topped by Bill Gates.
Business tycoon late Dhirubhai Ambani and construction magnate Pallonji Shapoorji Mistry are among industrialists chosen for this year's highest civilian awards that recognise the country's best talents.
Fresh warning letter to the company issued on Saturday comes after the facility was first inspected by the US drug regulator in September 2014
According to the report, the combined wealth of these 296 individuals is a staggering $478 billion, which is 22% of India’s GDP last year.